272 filings
8-K
BIIB
Biogen Inc
24 Apr 24
First quarter revenue $2.3 billion; GAAP diluted EPS $2.70; Non-GAAP diluted EPS $3.67
7:02am
8-K
BIIB
Biogen Inc
13 Feb 24
Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024
7:07am
8-K
BIIB
Biogen Inc
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:36pm
8-K
BIIB
Biogen Inc
8 Nov 23
Departure of Directors or Certain Officers
4:41pm
8-K
BIIB
Biogen Inc
8 Nov 23
Biogen reports third quarter 2023 results and updates full year 2023 guidance
7:02am
8-K/A
wlokzsbhk 45
28 Sep 23
Submission of Matters to a Vote of Security Holders
5:25pm
8-K
k8r1muj63qyx
26 Sep 23
Biogen Completes Acquisition of Reata Pharmaceuticals
5:25pm
8-K
xb06qhkh
1 Sep 23
Entry into a Material Definitive Agreement
4:36pm
8-K
j2fpp5b1p
31 Jul 23
Entry into a Material Definitive Agreement
7:00am
8-K
s8v8dxiivt86pldlk
28 Jul 23
Other Events
7:11am
8-K
ih1ogsnf4hy
25 Jul 23
Second quarter revenue $2,456 million; GAAP diluted EPS $4.07; Non-GAAP diluted EPS $4.02
7:03am
8-K
1ugeqcy1
29 Jun 23
Submission of Matters to a Vote of Security Holders
4:24pm
8-K
cq2u o5q7u
3 May 23
Other Events
9:02am
8-K
5vntbm
25 Apr 23
Company reports first quarter 2023 results and reaffirms full year 2023 guidance
7:02am
8-K
swtm3b
18 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:48pm
8-K
f1eylmz
8 Mar 23
Departure of Directors or Certain Officers
9:34pm
8-K
2vj5bom
15 Feb 23
Biogen advances significant potential growth drivers; Company reports full year 2022 results and provides full year 2023 guidance
7:03am
8-K
zccmlob
10 Nov 22
Biogen Names Christopher Viehbacher President and Chief Executive Officer
7:26am
8-K
bnnkxvcb8oy
25 Oct 22
Biogen Reports Third Quarter 2022 Results
7:08am
8-K/A
s3sif
20 Jul 22
Biogen Reports Second Quarter 2022 Results
3:08pm